TrialCancer medicine2022

Levetiracetam as a sensitizer of concurrent chemoradiotherapy in newly diagnosed glioblastoma: An open-label phase 2 study.

Kihwan Hwang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.